Avantax Acquires Summit Wealth Advocates Adding 7-person Team and $330 Million in Total Client Assets to Avantax’s Employee-based Model
DALLAS, Aug. 22, 2023 (GLOBE NEWSWIRE) — Avantax®, a leader in tax-focused financial planning and…
DALLAS, Aug. 22, 2023 (GLOBE NEWSWIRE) — Avantax®, a leader in tax-focused financial planning and…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Banner Health and nference, a science-first software company transforming healthcare by making biomedical…
MANILA, Aug 22, 2023 – (JCN Newswire) – Toyota Motor Corporation (TMC) announces that Toyota…
SANTA CLARA, CA, Aug 22, 2023 – (ACN Newswire) – Graid Technology Inc., the award-winning…
Kathmandu, Aug 22, 2023 – (ACN Newswire) – Esewa Money Transfer, the fastest growing digital-first…
SEATTLE, WA, Aug 22, 2023 – (ACN Newswire) – The Personalized Lifestyle Medicine Institute (PLMI)…
Santiago, Chile, Aug 22, 2023 – (ACN Newswire) – InvestChile, the Foreign Investment Promotion Agency,…
AeroVironment’s unmanned systems paired with Tomahawk Robotics’ AI-enabled technology will allow warfighters to operate various…
Innovative AI-powered email builder serves as all-in-one, time-saving solution for crafting captivating emails ORMOND BEACH,…
Global retail specialist Smollan and next-gen analytics software provider Pyramid Analytics collaborate to empower businesses…
AUSTIN, Texas–(BUSINESS WIRE)–Socotra, the leading provider of modern, cloud-based technology for insurers worldwide, announced today…
New collaboration increases access to genetic testing and can help identify patients with a high-risk…
New collaboration increases access to genetic testing and can help identify patients with a high-risk…
Virtual Webinar to be held September 5, 2023, at 11:00 AM Eastern Time AUSTIN, Texas,…
Virtual Webinar to be held September 5, 2023, at 11:00 AM Eastern Time AUSTIN, Texas,…
Data demonstrated that ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, directs macrophage polarization toward…
Data demonstrated that ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, directs macrophage polarization toward…
SANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…
REGAL Interim Analysis Expected by Late 2023/Early 2024 Enrollment Expected to be Completed in Q4…
SANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…